Ep 57 | Post-Election Outcome & 340B Implications
In this episode, Greg and Rob are joined by Rodney Whitlock, healthcare policy expert, to discuss the recent 2024 election results. They’ll discuss what the second Trump Administration might priori...
14 Nov 202454min
Ep 56 | 2024 General Election Outlook & 340B
In this episode, Greg and Rob are joined by Mike Strazzella, government affairs expert from Buchanan Ingersoll & Rooney, to discuss the upcoming general election, and what races may be critical to fut...
28 Okt 202455min
Ep 55 | All About 340B Modifiers
In this episode, Greg and Rob discuss the various uses of 340B billing modifiers. They’ll discuss some general considerations around what billing modifiers are used for, highlight differences between ...
14 Okt 202458min
Ep 54 | 340B Operations Discussion – “Clean Site” Locations
In this episode, Greg and Rob get back to 340B basics and have a conversation around the concept of “clean site” 340B-only locations. They discuss what “clean site” means in the world of 340B, what t...
1 Okt 202450min
Ep 53 | J&J 340B Rebate Model Follow-Up Discussion
In this episode, Greg and Rob catch up on developments surrounding the J&J 340B rebate proposal, including HRSA’s response. They’ll address some outstanding questions from the recent SpendMend webinar...
23 Sep 202452min
Ep 52 | 340B Smorgasbord - Contract Pharmacy Legislation, ADR, Section 1115 Waiver Days & 340B Rebate Models
In this episode, Greg and Rob are joined by healthcare attorney and 340B veteran Barbara Straub Williams. They cover a variety of topics, including an update on litigation targeting state-level contr...
3 Sep 20241h 15min
Ep 51 | CMS Medicaid Drug Rebate Program & “Covered Outpatient Drug” Definition
In this episode, Greg and Rob are joined by healthcare attorney Todd Nova to discuss a proposed rule change put forth by CMS in 2023 regarding the Medicaid Drug Rebate Program (MDRP), which includes a...
21 Aug 20241h 17min
